AnaptysBio stock whipsawed Wednesday despite promising results for its experimental rheumatoid arthritis treatment.

AnaptysBio may have ended last year on a low, but 2025 is looking up with the news that its PD-1 agonist rosnilimab has ...

AnaptysBio’s Phase IIb trial of its rheumatoid arthritis (RA) treatment, rosinilimab, has seen some patients achieve the ...

Indian scientists have created an innovative self-actuating drug delivery system for Rheumatoid Arthritis, providing precise ...

PORTLAND, KS, UNITED STATES, February 13, 2025 /EINPresswire / -- Rheumatoid arthritis is an autoimmune disorder, w ...

Rheumatoid arthritis (RA) is an autoimmune disorder affecting millions worldwide, causing chronic inflammation, debilitating ...

The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.

This article helps to dispel myths related to rheumatoid arthritis (RA) and raise awareness regarding it. From causes to ...

Researchers from the Institute of Nano Science and Technology (INST) Mohali, an autonomous institution of the Department of Science and Technology (DST), have developed an innovative “self-actuating” ...

Rheumatoid arthritis is an autoimmune condition ... Treatment: Arthritis treatment includes physical therapy, medications, and regenerative options like BMAC. Bursitis treatment focuses on rest ...

Marking Rheumatoid Arthritis Awareness Day 2025 on February 2, it's essential to shed light on the often-overlooked connection between RA and lung health. Can rheumatoid arthritis cause lung damage?

Indian researchers have made a significant leap in the treatment of Rheumatoid Arthritis (RA) with a revolutionary “self-actuating” drug delivery system. This cutting-edge approach aims to ...